Journal List > J Lipid Atheroscler > v.6(1) > 1059587

Shin, Park, Won, and Kim: Association between Metabotropic Glutamate Receptor 1 Polymorphism and Cardiovascular Disease in Korean Adults

Abstract

Objective

The mGluR1 (metabotropic glutamate receptor 1) gene, a G protein–coupled receptor, is known to mediate perceptions of umami tastes. Genetic variation in taste receptors may influence dietary intake, and in turn have an impact on nutritional status and risk of chronic disease. We investigated the association of mGluR1 rs2814863 polymorphism with lipid profiles and cardiovascular disease (CVD) risk, together with their modulation by macronutrient intake in Korean adults.

Methods

The subjects consisted of 8,380 Koreans aged 40-69 years participating in the Anseong and Ansan Cohort Study, which was a part of the Korean Genome Epidemiology Study (KoGES). Data was collected using self-administered questionnaires, anthropometric measurements, and blood chemical analysis.

Results

Carriers of C allele at mGluR1 rs2814863 was associated with decreased high density lipoprotein cholesterol (HDL-C) and increased triglyceride as compared to carriers of TT. Also, carriers of the C allele showed higher fat intake and lower carbohydrate intake than those with carriers of TT. After adjustment for multiple testing using false-discovery rate method, the significant difference of HDL-C, triglyceride, dietary fat, and carbohydrate across genotypes disappeared. Gene-diet interaction effects between rs2814863 and macronutrients intake were not significantly associated with HDL-C and triglyceride levels. However, carriers of C allele demonstrated significantly higher odds of CVD {odds ratio=1.13, 95% CI=1.02-1.25} compared with carriers of TT.

Conclusion

Our findings support significant associations between the mGluR1 rs2814863 genotype and CVD-related variables in Korean adults. However, these associations are not modified by macronutrient intake.

REFERENCES

1. GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015; 385:117–171.
2. Verschuren WM, Jacobs DR, Bloemberg BP, Kromhout D, Menotti A, Aravanis C, et al. Serum total cholesterol and long-term coronary heart disease mortality in different cultures. Twenty-five-year follow-up of the seven countries study. JAMA. 1995; 274:131–136.
crossref
3. Krauss RM. Triglycerides and atherogenic lipoproteins: rationale for lipid management. Am J Med. 1998; 105:58S–62S.
crossref
4. Forrester JS. Triglycerides: risk factor or fellow traveler? Curr Opin Cardiol. 2001; 16:261–264.
crossref
5. Malloy MJ, Kane JP. A risk factor for atherosclerosis: triglyceride-rich lipoproteins. Adv Intern Med. 2001; 47:111–136.
6. Varady KA, Jones PJ. Combination diet and exercise interventions for the treatment of dyslipidemia: an effective preliminary strategy to lower cholesterol levels? J Nutr. 2005; 135:1829–1835.
crossref
7. Vogel JH, Bolling SF, Costello RB, Guarneri EM, Krucoff MW, Longhurst JC, et al. Integrating complementary medicine into cardiovascular medicine. A report of the american college of cardiology foundation task force on clinical expert consensus documents (writing committee to develop an expert consensus document on complementary and integrative medicine). J Am Coll Cardiol. 2005; 46:184–221.
8. Hegsted DM, Ausman LM. Diet, alcohol and coronary heart disease in men. J Nutr. 1988; 118:1184–1189.
crossref
9. Artaud-Wild SM, Connor SL, Sexton G, Connor WE. Differences in coronary mortality can be explained by differences in cholesterol and saturated fat intakes in 40 countries but not in France and Finland. A paradox. Circulation. 1993; 88:2771–2779.
crossref
10. Acheson KJ. Carbohydrate for weight and metabolic control: where do we stand? Nutrition. 2010; 6:141–145.
crossref
11. Lee YC, Lai CQ, Ordovas JM, Parnell LD. A database of gene-environment interactions pertaining to blood lipid traits, cardiovascular disease and type 2 diabetes. J Data Mining Genomics Proteomics. 2011; 2:106.
crossref
12. Ordovas JM. Nutrigenetics, plasma lipids, and cardiovascular risk. J Am Diet Assoc. 2006; 106:1074–1081.
crossref
13. Zhang F, Klebansky B, Fine RM, Xu H, Pronin A, Liu H, et al. Molecular mechanism for the umami taste synergism. Proc Natl Acad Sci U S A. 2008; 105:20930–20934.
crossref
14. Donaldson LF, Bennett L, Baic S, Melichar JK. Taste and weight: is there a link? Am J Clin Nutr. 2009; 90:800S–803S.
crossref
15. Pepino MY, Finkbeiner S, Beauchamp GK, Mennella JA. Obese women have lower monosodium glutamate taste sensitivity and prefer higher concentrations than do normal-weight women. Obesity (Silver Spring). 2010; 18:959–965.
crossref
16. Raliou M, Wiencis A, Pillias AM, Planchais A, Eloit C, Boucher Y, et al. Nonsynonymous single nucleotide polymorphisms in human tas1r1, tas1r3, and mGluR1 and individual taste sensitivity to glutamate. Am J Clin Nutr. 2009; 90:789S–799S.
crossref
17. Shigemura N, Shirosaki S, Ohkuri T, Sanematsu K, Islam AA, Ogiwara Y, et al. Variation in umami perception and in candidate genes for the umami receptor in mice and humans. Am J Clin Nutr. 2009; 90:764S–769S.
crossref
18. Garcia-Bailo B, Toguri C, Eny KM, El-Sohemy A. Genetic variation in taste and its influence on food selection. OMICS. 2009; 13:69–80.
crossref
19. Lim S, Jang HC, Lee HK, Kimm KC, Park C, Cho NH. A rural-urban comparison of the characteristics of the metabolic syndrome by gender in Korea: the Korean Health and Genome Study (KHGS). J Endocrinol Invest. 2006; 29:313–319.
crossref
20. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985; 28:412–419.
crossref
21. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972; 18:499–502.
crossref
22. Ahn Y, Lee JE, Paik HY, Lee HK, Jo I, Kimm K. Development of a semi-quantitative food frequency questionnaire based on dietary data from the Korea National Health and Nutrition Examination Survey. Nutr Sci. 2003; 6:173–184.
23. Ahn Y, Lee JE, Cho NH, Shin C, Park C, Oh BS, et al. Validation and calibration of semi-quantitative food frequency questionnaire: with participants of the Korean Health and Genome Study. Korean J Community Nutr. 2004; 9:173–182.
24. Korean Nutrition Society. Korean Nutrition Society. Recommended dietary allowances for Koreans. 7th ed. Seoul: Korean Nutrition Society; 2000. pp. 259-464.
25. Cho YS, Go MJ, Kim YJ, Heo JY, Oh JH, Ban HJ, et al. A large-scale genome-wide association study of Asian populations uncovers genetic factors influencing eight quantitative traits. Nat Genet. 2009; 41:527–534.
crossref
26. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc B. 1995; 57:289–300.
crossref
27. Luscombe-Marsh ND, Smeets AJ, Westerterp-Plantenga MS. Taste sensitivity for monosodium glutamate and an increased liking of dietary protein. Br J Nutr. 2008; 99:904–908.
crossref
28. Lai CQ, Corella D, Demissie S, Cupples LA, Adiconis X, Zhu Y, et al. Dietary intake of n-6 fatty acids modulates effect of apolipoprotein A5 gene on plasma fasting triglycerides, remnant lipoprotein concentrations, and lipoprotein particle size: the Framingham Heart Study. Circulation. 2006; 113:2062–2070.
29. Moreno JA, Pérez-Jiménez F, Marín C, Gómez P, Pérez-Martínez P, Moreno R, et al. The effect of dietary fat on LDL size is influenced by apolipoprotein E genotype in healthy subjects. J Nutr. 2004; 134:2517–2522.
crossref

Table 1.
General characteristics of study subjects
Male (n=3,993) Female (n=4,387)
Age (years) 51.6±0.1 52.6±0.2
Height (cm) 167.0±0.1 153.8±0.1
Weight (kg) 67.8±0.2 59.0±0.1
Waist circumstance (cm) 83.7±0.1 81.6±0.2
BMI (kg/m2) 24.3±0.1 24.9±0.1
Blood pressure (mm Hg)
 Systolic 117.1±0.3 117.2±0.3
 Diastolic 76.1±0.2 73.8±0.2
Alcohol intake (g/d) 26.7±0.6 5.3±0.3
Exercise (MET-h/d) 4.0±0.1 3.3±0.1
Current smokers (%) 49.3 3.5
High school education (%) 58.7 32.0
Total cholesterol (mg/dL) 198.6±0.6 199.5±0.6
HDL-C (mg/dL) 47.7±0.2 50.9±0.2
LDL-C (mg/dL) 118.9±0.6* 121.6±0.5
Triglycerides (mg/dL) 171.0±2.0 138.1±1.4
HbA1c (%) 5.8±0.02 5.8±0.01
Fasting glucose (mg/dL) 95.2±0.4 90.6±0.3
Fasting insulin (μIU/mL) 7.1±0.1 8.0±0.1
HOMA-IR (arbitrary units) 1.7±0.02 1.8±0.02
Dietary intake
 Energy intake (kcal) 1992.3±8.6 1830.9±8.5
 Protein (% of energy) 13.6±0.04 13.3±0.04
 Fat (% of energy) 15.4±0.1 13.4±0.1
 Carbohydrate (% of energy) 69.8±0.1 72.4±0.1
mGluR1 rs2814863 T>C (MAF/HWE) 0.37 / 0.94 0.38 / 0.44

BMI; body mass index, MET; metabolic equivalent task, HDL-C; high density lipoprotein cholesterol, LDL-C; low density lipoprotein cholesterol, HbA1c; Hemoglobin A1c, HOMA-IR; homeostasis model assessment of insulin resistance, MAF; Minor allele frequency, HWE; Hardy-Weinberg equilibrium.

The data represent the means±SEM and p values obtained in the independent t-test or chi-square test for differences between male and female participants (*p<0.001, p<0.0001).

Fasting glucose, Fasting insulin, HOMA-IR were measured in 3,891 male and 4,251 female participants.

If triglycerides were <400 mg/dL, LDL-C=[Total cholesterol−{HDL-C+(triglyceride/5)}], and LDL-C was measured in 3,823 male and 4,309 female participants.

Table 2.
Comparison of characteristics according to mGluR1 rs2814863 genotype
TT (n=3,286) TC+CC (n=5,094) p value
Sex (Male/Female) 48.3/51.7 47.2/52.8 0.341
Age (years) 52.2±0.2 52.1±0.1 0.669
Height (cm) 160.2±0.2 160.0±0.1 0.724
Weight (kg) 63.2±0.2 63.2±0.1 0.637
Waist circumstance (cm) 82.5±0.2 82.6±0.1 0.419
BMI (kg/m2)* 24.4 (22.5-26.4) 24.5 (22.6-26.6) 0.470
Blood pressure (mm Hg)
 Systolic 116.8±0.3 117.4±0.3 0.083
 Diastolic 74.7±0.2 75.0±0.2 0.158
Alcohol intake (g/d)* 9.7 (2.9-28.1) 10.0 (2.9-27.9) 0.792
Exercise (MET-h/d) 3.7±0.1 3.6±0.1 0.482
Current smokers (%) 24.8 25.9 0.069
High school education (%) 43.9 45.3 0.120
Total cholesterol (mg/dL)* 196 (173-222) 197 (173-222) 0.967
HDL-C (mg/dL)* 48 (42-56) 47 (41-56) 0.023
LDL-C (mg/dL) 120.4±0.6 120.2±0.5 0.788
Triglycerides (mg/dL)* 123 (87-181) 127 (88-185) 0.030
HbA1c (%)* 5.6 (5.3-5.9) 5.6 (5.4-5.9) 0.310
Fasting glucose (mg/dL)* 88 (83-95) 88 (82-95) 0.317
Fasting insulin (μIU/mL)* 6.9 (5.2-9.6) 7.0 (5.1-9.5) 0.352
HOMA-IR (arbitrary units)* 1.5 (1.1-2.2) 1.5 (1.1-2.2) 0.270
Dietary intake
 Energy intake (kcal) 1916.2±9.7 1902.4±7.9 0.305
 Protein (% of energy)* 13.2 (11.8-14.7) 13.3 (11.9-14.9) 0.077
 Fat (% of energy) 14.1±0.1 14.4±0.2 0.009
 Carbohydrate (% of energy) 71.3±0.1 71.0±0.1 0.016

BMI; body mass index, MET; metabolic equivalent task, HDL-C; high density lipoprotein cholesterol, LDL-C; low density lipoprotein cholesterol, HbA1c; Hemoglobin A1c, HOMA-IR; homeostasis model assessment of insulin resistance The data represent the means±SEM and p values obtained in the generalized linear model (GLM), with adjustment for age and gender.

Fasting glucose, Fasting insulin, HOMA-IR were measured in 3,891 male and 4,251 female participants.

If triglycerides were <400 mg/dl, LDL-C=[Total cholesterol−{HDL-C+(triglyceride/5)}], and LDL-C was measured in 3,202 individuals with the AA genotype and 4,940 with the AG+GG genotype.

* Values are median (interquartile range).

Table 3.
Interaction between mGluR1 rs2814863 genotype and dietary intake on lipid profiles
HDL-C (mg/dL)
Triglyceride (mg/dL)
TT (n=3,286) TC+CC (n=5,094) p value p interaction TT (n=3,286) TC+CC (n=5,094) p value p interaction
Energy (kcal)
 <1827.5 48 (41-56) 48 (41-56) 0.344 0.132 122 (87-174) 126 (88-183) 0.062 0.903
 ≥1827.5 48 (42-56) 47 (40-56) 0.030 124 (88-186) 128 (88-187) 0.242
Protein (%E)
 <13.3 48 (41-56) 48 (41-56) 0.564 0.187 123 (89-180) 126 (89-181) 0.424 0.261
 ≥13.3 48 (42-57) 47 (41-56) 0.007 122 (86-182) 128 (87-189) 0.023
Fat (%E)
 <14.0 48 (42-56) 47 (41-55) 0.072 0.742 124 (89-181) 127 (90-186) 0.106 0.252
 ≥14.0 48 (42-56) 47 (41-56) 0.139 122 (86-180) 128 (87-184) 0.158
Carbohydrate
 <71.6 48 (42-56) 48 (41-56) 0.281 0.788 124 (86-182) 127 (86-183) 0.508 0.567
 ≥71.6 48 (42-56) 47 (40-55) 0.038 122 (89-180) 128 (90-187) 0.023

HDL-C; high density lipoprotein cholesterol, LDL-C; low density lipoprotein cholesterol

The participants were categorized by total energy intake and the percentage of energy they obtained from their median levels of protein, fat, and carbohydrate.

The data represent the median (interquartile range) and p values obtained in the generalized linear model (GLM), p interactions obtained in logistic regression model after adjustment for age and gender.

Table 4.
Association between mGluR1 rs2814863 genotype and cardiovascular disease
TT (n=3,286) TC+CC (n=5,094) p value
Hypertension 1.0 1.11 (1.00-1.23) 0.047
Myocardial infarction 1.0 1.17 (0.72-1.90) 0.531
Coronary artery disease 1.0 1.43 (0.86-2.37) 0.171
Congestive heart failure 1.0 0.89 (0.59-1.34) 0.582
Cardiovascular disease 1.0 1.13 (1.02-1.25) 0.020

The data are represented the as odds ratio (95% confidence interval) and p values obtained in logistic regression model, after adjustment for age, gender, and dietary fat intake.

TOOLS
Similar articles